Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,516,400
+$341,500 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#1,780
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cherokee Insurance Co holds $24,401,209 across 9 Drug Manufacturers - General names. ABBV ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,800 | $12,953,845 | |
| 2 | PFE |
Pfizer Inc
|
126,947 | $3,056,883 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,000 | $2,516,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,498 | $1,862,993 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
30,600 | $1,763,172 | |
| 6 | AZN |
Astrazeneca PLC
|
6,000 | $1,137,720 | |
| 7 | NVS |
Novartis AG
|
3,500 | $548,520 | |
| 8 | SNY |
Sanofi
|
7,213 | $307,706 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,516,400 | 10,000 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $2,174,900 | 10,000 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $2,284,900 | 10,000 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,315,400 | 10,000 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,856,200 | 10,000 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,095,200 | 10,000 | Shares | Defined | 2025-08-21 | |
| 2024-12-31 | $1,777,000 | 10,000 | Shares | Defined | 2025-08-21 | |
| No filing history on record for this holder in this stock. | ||||||